Trial intelligence / Profile preview

Tramadol HCl Effects on Cardiac Repolarization

NCT02307864Phase 1Completed

Sponsor
Janssen Scientific Affairs
Start
Dec 2014
Primary completion
Aug 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of tramadol in pain (4 arms), sponsored by Janssen Scientific Affairs. Primary endpoint: Change From Baseline in QTc Interval. Started Dec 2014; status: completed.

02

Drugs

tramadol
03

Conditions

pain

Beyond the preview

Go deeper on NCT02307864.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02307864.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call